This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

TAK-475

Takeda Pharmaceutical Company Ltd

Drug Names(s): Lapaquistat

Description: TAK-475 is an inhibitor of squalene synthase, an enzyme in the cholesterol synthesis pathway. Squalene synthase acts further down the cholesterol synthesis pathway than HMG CoA Reductase, and as a result, may avoid certain toxicities of statins.


TAK-475 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug